The present disclosure relates to HIF-1\u03b1 prolyl hydroxylase inhibitors, compositions which comprise the HIF-1\u03b1 prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease, Coronary Artery Disease, heart failure, ischemia, and anemia. The system utilizes symbolic cognitive architectures and inference processing algebras allowing the system to respond to open, incomplete, andor unknown problem domains, offering flexibility in the case of unexpected changes in the security environment. The first and second components arise from the shaping of a junction region between branches of the second intake duct adjacent the chamber. lock, close only, raise, and tilt to provide angular pivoting of window sash, that allow three levels of security, i.